Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients

被引:46
作者
Drulovic, J [1 ]
MostaricaStojkovic, M [1 ]
Levic, Z [1 ]
Stojsavljevic, N [1 ]
Pravica, V [1 ]
Mesaros, S [1 ]
机构
[1] UNIV BELGRADE, SCH MED, INST MICROBIOL & IMMUNOL, YU-11000 BELGRADE, YUGOSLAVIA
关键词
interleukin-12; tumor necrosis factor-alpha; multiple sclerosis; cerebrospinal fluid;
D O I
10.1016/S0022-510X(96)05320-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Concentrations of interleukin (IL)-12 and tumor necrosis factor-alpha (TNF-alpha) in cerebrospinal fluid (CSF) were measured in patients with multiple sclerosis (MS) and control patients with non-inflammatory neurological diseases (NIND) by an enzyme-linked immunosorbent assay. TNF-alpha was detectable in the CSF of 60% of the patients with active MS, none of those with inactive MS and 29% of patients with NIND. CSF concentrations of TNF-alpha correlated with the degree of disability in MS patients (P<0.05). Detectable levels of IL-12 were found in 10% of the MS CSF samples and 18% of NIND CSF samples. There was a significant relationship between CSF concentrations of IL-12 and those of TNF-alpha in MS patients (P<0.05); no relationship was observed between the presence of IL-12 and disease activity or severity. These findings further stress the involvement of T helper 1 type-response within the central nervous system in MS. (C) 1997 Elsevier Science BV.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 42 条
[1]   COOPERATION OF NATURAL-KILLER-CELL STIMULATORY FACTOR INTERLEUKIN-12 WITH OTHER STIMULI IN THE INDUCTION OF CYTOKINES AND CYTOTOXIC CELL-ASSOCIATED MOLECULES IN HUMAN T-CELLS AND NK-CELLS [J].
ASTEAMEZAGA, M ;
DANDREA, A ;
KUBIN, M ;
TRINCHIERI, G .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :480-492
[2]   VASCULAR CELL-ADHESION MOLECULE-1 MODULATION BY TUMOR-NECROSIS-FACTOR IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
BARTEN, DM ;
RUDDLE, NH .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 51 (02) :123-133
[3]   INCREASED PRODUCTION OF INTERFERON GAMMA AND TUMOR NECROSIS FACTOR PRECEDES CLINICAL MANIFESTATION IN MULTIPLE-SCLEROSIS - DO CYTOKINES TRIGGER OFF EXACERBATIONS [J].
BECK, J ;
RONDOT, P ;
CATINOT, L ;
FALCOFF, E ;
KIRCHNER, H ;
WIETZERBIN, J .
ACTA NEUROLOGICA SCANDINAVICA, 1988, 78 (04) :318-323
[4]   THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS [J].
CANNELLA, B ;
RAINE, CS .
ANNALS OF NEUROLOGY, 1995, 37 (04) :424-435
[5]  
CORREALE J, 1995, J IMMUNOL, V154, P2959
[6]   THE ROLE OF GENETIC-FACTORS IN MULTIPLE-SCLEROSIS SUSCEPTIBILITY [J].
EBERS, GC ;
SADOVNICK, AD .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 54 (1-2) :1-17
[7]  
FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341
[8]   INTERLEUKIN-12 [J].
GERMANN, T ;
RUDE, E .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (02) :103-112
[9]   CYTOKINE ACCUMULATIONS IN CSF OF MULTIPLE-SCLEROSIS PATIENTS - FREQUENT DETECTION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR BUT NOT INTERLEUKIN-6 [J].
HAUSER, SL ;
DOOLITTLE, TH ;
LINCOLN, R ;
BROWN, RH ;
DINARELLO, CA .
NEUROLOGY, 1990, 40 (11) :1735-1739
[10]  
HENDRZAK JA, 1995, LAB INVEST, V72, P619